William Hodder Email & Phone Number

California, United States

Boston, MA, US

San Diego, CA, US

Assist private (pre-funded and funded) and public biotech companies with various fundraising, corporate development, licensing and marketing activities.

Houston, Texas, US

Newark, California, US

Corporate Officer managing Corporate Development for a peptide therapeutics company focused on gastrointestinal diseases utilizing a proprietary platform technology. Responsible for licensing, M&A, and other significant contracting activities including real estate. Completed the out-licensing of a pre-clinical oral peptide program, PTG-200, to Janssen in.

Assist private (pre-funded and funded) and public biotech companies with various fundraising, corporate development, licensing and marketing activities.

Founded company to seek funding for the development of LDN-193189, a small molecule BMP/ALK receptor kinase inhibitor discovered at Massachusetts General/Brigham and Women’s Hospital and the discovery of 2nd generation ALK inhibitors.

San Francisco, CA, US

• Corporate officer and member of the executive management team. Responsible for all licensing and M&A activity and ongoing partner Alliance Management. Managed a team of 4 – 6 professionals.Significant activities.
• Out-licensing of HIF prolyl hydroxylase inhibitors for anemia indications to Yamanouchi for the Japan territory in April 2004. Deal terms included $18.5M cash upfront, $30.5M equity investment and significant.
• Out-licensing of HIF prolyl hydroxylase inhibitors for anemia indications to Astellas for the European, South Africa and Middle East territories in February 2006. Deal terms included $300M cash upfront, $50M equity.
• Completed transactions to secure cell lines and manufacturing capacity for FibroGen’s monoclonal antibody program.
• In-licensed or acquired additional intellectual property from various academic institutions and companies to support the therapeutic and biomaterial programs at FibroGen. Acquired an academic spinoff company to support.
• Executed feasibility and commercial development agreements for the biomaterials program with leading biotech, pharmaceutical, medical device and drug delivery companies.

Negotiated and executed feasibility agreements with biotech and pharmaceutical companies for pulmonary drug delivery technology. Developed and implemented yearly strategic business development and marketing plans. Directed advertising and public relations activities to support corporate development goals. Directed deal negotiation and due diligence process.

Responsible for the pre-launch and launch marketing activities for AVITA, a prescription acne product. Activities included the development and execution of clinical study publication strategy, development of speakers’ bureau, and the selection and direction of advertising agency. Directed various marketing research activities leading to the formulation of.

Responsible for managing advertising agency through the creation of marketing materials for personal and non-personal promotion. Developed yearly marketing plans including family positioning strategy for all anti-inflammatory products in Ciba’s portfolio. Directed market research for positioning and concept testing of future line extensions of VOLTAREN.

Performed competitor analysis of current and future products in prescription analgesia market. Initiatedand developed physician focus groups to identify physicians’ perceptions and use of prescriptionanalgesics. Analyzed market issues to determine positioning of new prescription analgesic. Investigated product concepts for launch strategy and presented.

Lawrence Township, NJ, US

Promoted prescription and over-the-counter products to doctors, pharmacies, hospitals and wholesalers. Metropolitan Detroit sales territory.

Promoted prescription and over-the-counter products to doctors, pharmacies, hospitals and wholesalers. Pontiac, Michigan sales territory. Marion Labs is now part of Sanofi.

Master Of Business Administration

Bachelor Of Science, Biology